SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001867096-24-000017
Filing Date
2024-01-31
Accepted
2024-01-31 17:05:13
Documents
1
Period of Report
2024-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1706738697.html 4  
1 FORM 4 wk-form4_1706738697.xml 4 3521
  Complete submission text file 0001867096-24-000017.txt   4982
Mailing Address DURATA THERAPEUTICS, INC. 89 HEADQUARTERS PLAZA NORTH, 14TH FLOOR MORRISTOWN NJ 07960
Business Address
Shannon John Patrick Jr (Reporting) CIK: 0001553595 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40880 | Film No.: 24583843

Mailing Address 1375 WEST FULTON STREET, SUITE 1300 CHICAGO IL 60607
Business Address 1375 WEST FULTON STREET, SUITE 1300 CHICAGO IL 60607 844-445-5704
Xeris Biopharma Holdings, Inc. (Issuer) CIK: 0001867096 (see all company filings)

IRS No.: 871082097 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)